EAST HANOVER, N.J., Nov. 10, 2016 /PRNewswire/ -- Novartis Pharmaceuticals Corporation announced today the launch of Together in HF ( www.TogetherinHF.com) - a social network for members of the heart failure (HF) community - in partnership with national patient and professional organizations supporting heart health. Together in HF is the first social network for HF patients and caregivers to share their stories, and support and inspire each other. Members can access HF information and other resources from leading patient and caregiver advocacy groups as well as professional medical associations. Experience the interactive Multimedia News Release here: https://www.multivu.com/players/English/7968951-novartis-heart-failure-social-networking-platform "Our commitment to patients goes far beyond medicine, and we are proud to help launch this new, innovative social network for heart failure patients and their loved ones," said Fabrice Chouraqui, President of Novartis Pharmaceuticals Corporation. "Together in HF is a collective effort that brings together the expertise and resources of many organizations with a special focus on the unique social and emotional needs of people who are living with heart failure." Strong social support is important for the overall well-being of a heart failure patient, according to Mary McGowan, CEO, WomenHeart: The National Coalition for Women with Heart Disease. "As a founding partner of Together in HF, we strongly believe in helping those living with heart failure manage their emotional and psychosocial health," she said. "It is often these less tangible effects of the condition that are overshadowed by the physical signs. Yet we know that focusing on the whole patient experience greatly contributes to the overall health of the patient." Together in HF is designed to meet these needs by providing a consistent support system that allows patients and caregivers to seek the information and resources valuable to them, when they need it. Support beyond the peer community is also available through access to emotional support platforms staffed by health researchers and clinicians. Information available on the site is meant to enhance patients' dialogue with their healthcare professionals about their condition.